Related Experiment Video

Updated: Jun 26, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Discovery of Natural Magnolol/Dunnianol Inspired Derivatives as Potent Antibacterials against Methicillin-Resistant

Shengnan Xu1, Yan Wang2, Shudan Zheng2

  • 1Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan Province, China.

Journal of Agricultural and Food Chemistry
|June 25, 2026
PubMed

Insights

A new derivative, 5c, shows potent activity against methicillin-resistant Staphylococcus aureus (MRSA) in livestock. This novel agent is safe, effective in treating skin infections, and offers a promising alternative for animal husbandry.

Area of Science:

  • Veterinary Medicine
  • Microbiology
  • Medicinal Chemistry

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat to livestock due to drug resistance and toxicity.
  • Existing treatments necessitate the development of novel, safe, and resistance-evading anti-MRSA agents for animal husbandry.

Purpose of the Study:

  • To develop and evaluate novel anti-MRSA derivatives based on magnolol and dunnianol.
  • To identify a potent, safe, and non-resistant anti-MRSA candidate for veterinary applications.

Main Methods:

  • Synthesis and bioactivity screening of magnolol and dunnianol derivatives.
  • Determination of Minimum Inhibitory Concentrations (MICs) and hemolysis (HC50).
  • Assessment of mechanism of action, plasma stability, cytotoxicity, and in vivo efficacy in a murine MRSA skin infection model.

Main Results:

  • Derivative 5c exhibited potent activity (MICs 1-2 μg/mL) against MRSA strains with low hemolysis (HC50 = 129.66 μg/mL) and a high selectivity index (64.83).
  • 5c rapidly disrupted bacterial membrane integrity, demonstrated no resistance tendency, and possessed good plasma stability.
  • In vivo studies showed 5c reduced abscess size and inflammation comparable to vancomycin, with no observed nephrotoxicity or adverse effects on major organs.

Conclusions:

  • Derivative 5c is a highly promising anti-MRSA agent with a favorable safety profile for veterinary use.
  • 5c's rapid membrane disruption mechanism and lack of resistance development make it a valuable candidate for combating MRSA in animal husbandry.
Keywords:
antibacterial activitymagnolol/dunnianolmethicillin-resistant Staphylococcus aureus (MRSA)structural modificationtargeting bacterial cell membranes

More Related Videos

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü602809:08

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028

Published on: January 13, 2017

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...